Literature DB >> 20399708

Neuropeptides: keeping the balance between pathogen immunity and immune tolerance.

Elena Gonzalez-Rey1, Doina Ganea, Mario Delgado.   

Abstract

Various neuropeptides have emerged recently as potent immunomodulatory factors with potential for their therapeutic use in immune disorders. Here we highlight the most recent data relevant in the field and we offer our opinion on how neuropeptide therapy might impact clinical immune diseases, and the challenges in this field that must be overcome before achieving medical progress. We also review recent reports describing the antimicrobial effects showed by some neuropeptides and the therapeutic, physiological, and evolutionary consequences of this new finding. Finally, we discuss how a physiologically functional neuropeptide system contributes to general health and how neuropeptides educate our immune system to be tolerant. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20399708      PMCID: PMC3417345          DOI: 10.1016/j.coph.2010.03.003

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  54 in total

Review 1.  Anti-inflammatory neuropeptide receptors: new therapeutic targets for immune disorders?

Authors:  Elena Gonzalez-Rey; Mario Delgado
Journal:  Trends Pharmacol Sci       Date:  2007-08-03       Impact factor: 14.819

2.  Neuropeptide modulators of high mobility group box 1 secretion as potential therapeutic agents for severe sepsis.

Authors:  Mitchell P Fink
Journal:  Am J Pathol       Date:  2008-04-10       Impact factor: 4.307

3.  Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis: altered expression and signal in immune cells.

Authors:  Mario Delgado; Gema Robledo; Blanca Rueda; Nieves Varela; Francisco O'Valle; Pedro Hernandez-Cortes; Marta Caro; Gisela Orozco; Elena Gonzalez-Rey; Javier Martin
Journal:  Arthritis Rheum       Date:  2008-04

4.  Neuropeptides rescue mice from lethal sepsis by down-regulating secretion of the late-acting inflammatory mediator high mobility group box 1.

Authors:  Alejo Chorny; Mario Delgado
Journal:  Am J Pathol       Date:  2008-04-01       Impact factor: 4.307

5.  Differential expression of vasoactive intestinal peptide and its functional receptors in human osteoarthritic and rheumatoid synovial fibroblasts.

Authors:  Yasmina Juarranz; Irene Gutiérrez-Cañas; Begoña Santiago; Mar Carrión; José L Pablos; Rosa P Gomariz
Journal:  Arthritis Rheum       Date:  2008-04

6.  In vivo delivery of lentiviral vectors expressing vasoactive intestinal peptide complementary DNA as gene therapy for collagen-induced arthritis.

Authors:  Mario Delgado; Miguel G Toscano; Karim Benabdellah; Marien Cobo; Francisco O'Valle; Elena Gonzalez-Rey; Francisco Martín
Journal:  Arthritis Rheum       Date:  2008-04

7.  Vasoactive intestinal peptide inhibits cyclooxygenase-2 expression in activated macrophages, microglia, and dendritic cells.

Authors:  Elena Gonzalez-Rey; Mario Delgado
Journal:  Brain Behav Immun       Date:  2007-09-07       Impact factor: 7.217

8.  Anti-microbial action of melanocortin peptides and identification of a novel X-Pro-D/L-Val sequence in Gram-positive and Gram-negative bacteria.

Authors:  Mirren Charnley; Arthur J G Moir; C W Ian Douglas; John W Haycock
Journal:  Peptides       Date:  2008-02-15       Impact factor: 3.750

9.  Ingested (oral) alpha-MSH inhibits acute EAE.

Authors:  Staley A Brod; Zachary M Hood
Journal:  J Neuroimmunol       Date:  2007-11-26       Impact factor: 3.478

10.  Vasoactive intestinal peptide and regulatory T-cell induction: a new mechanism and therapeutic potential for immune homeostasis.

Authors:  Elena Gonzalez-Rey; Mario Delgado
Journal:  Trends Mol Med       Date:  2007-04-27       Impact factor: 11.951

View more
  13 in total

Review 1.  Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions.

Authors:  Mario Delgado; Doina Ganea
Journal:  Amino Acids       Date:  2011-12-03       Impact factor: 3.520

Review 2.  Diabetes tolerogenic vaccines targeting antigen-specific inflammation.

Authors:  Shuang Geng; Huiyuan Zhang; Xian Zhou; Yue He; Xiaoqian Zhang; Xiaoping Xie; Chaofan Li; Zhonghuai He; Qingling Yu; Yiwei Zhong; Douglas B Lowrie; Guoxing Zheng; Bin Wang
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Vasoactive intestinal peptide/vasoactive intestinal peptide receptor relative expression in salivary glands as one endogenous modulator of acinar cell apoptosis in a murine model of Sjögren's syndrome.

Authors:  V Hauk; M Calafat; L Larocca; L Fraccaroli; E Grasso; R Ramhorst; C Pérez Leirós
Journal:  Clin Exp Immunol       Date:  2011-12       Impact factor: 4.330

Review 4.  The neuropeptide vasoactive intestinal peptide: direct effects on immune cells and involvement in inflammatory and autoimmune diseases.

Authors:  D Ganea; K M Hooper; W Kong
Journal:  Acta Physiol (Oxf)       Date:  2014-12-11       Impact factor: 6.311

5.  Inflammation and the nervous system: the connection in the cornea in patients with infectious keratitis.

Authors:  Andrea Cruzat; Deborah Witkin; Neda Baniasadi; Lixin Zheng; Joseph B Ciolino; Ula V Jurkunas; James Chodosh; Deborah Pavan-Langston; Reza Dana; Pedram Hamrah
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-11       Impact factor: 4.799

6.  Defects in the vasoactive intestinal peptide (VIP)/VPAC system during early stages of the placental-maternal leucocyte interaction impair the maternal tolerogenic response.

Authors:  L Fraccaroli; E Grasso; V Hauk; M Cortelezzi; G Calo; C Pérez Leirós; R Ramhorst
Journal:  Clin Exp Immunol       Date:  2012-12       Impact factor: 4.330

Review 7.  Mammalian Neuropeptides as Modulators of Microbial Infections: Their Dual Role in Defense versus Virulence and Pathogenesis.

Authors:  Daria Augustyniak; Eliza Kramarska; Paweł Mackiewicz; Magdalena Orczyk-Pawiłowicz; Fionnuala T Lundy
Journal:  Int J Mol Sci       Date:  2021-04-01       Impact factor: 5.923

8.  VIP boosts regulatory T cell induction by trophoblast cells in an in vitro model of trophoblast-maternal leukocyte interaction.

Authors:  Laura Fraccaroli; Esteban Grasso; Vanesa Hauk; Daniel Paparini; Elizabeth Soczewski; Gil Mor; Claudia Pérez Leirós; Rosanna Ramhorst
Journal:  J Leukoc Biol       Date:  2015-04-15       Impact factor: 6.011

9.  NOP Receptor Ligands as Potential Agents for Inflammatory and Autoimmune Diseases.

Authors:  Elaine C Gavioli; Pedro R T Romão
Journal:  J Amino Acids       Date:  2011-11-17

10.  Missing and Possible Link between Neuroendocrine Factors, Neuropsychiatric Disorders, and Microglia.

Authors:  Takahiro A Kato; Kohei Hayakawa; Akira Monji; Shigenobu Kanba
Journal:  Front Integr Neurosci       Date:  2013-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.